APRE vs CE · $10.4M cap vs rev $10.28B
Aprea Therapeutics Inc (APRE) versus Celanese Corporation (CE) — a side-by-side from cached financials, not a winner call.
Aprea Therapeutics Inc (APRE) is a biotechnology company listed on US.
Celanese Corporation (CE) is a chemicals company listed on US.
APRE does not have a complete income-statement cache yet.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
APRE currently screens at market cap $10.4M. CE currently screens at market cap $5.92B.
Not investment advice. Open the APRE and CE stock pages for the full models.
Not investment advice.